Novel antibody discovery

Theomics is entering a new area of novel antibody discovery and development led by our CSO, Dr. Raman Govindarajan. Dr. Govindarajan brings with him more than three decades of industry experience including stints with Sanofi, Johnson & Johnson, Jubilant, Unilever where he built and nurtured high performance teams in discovery biology and novel drug discovery and development. He has developed and pioneered novel methods of target ID/ validation and will be expanding on these areas in addition to novel antibody discovery and development.